CI Investments Inc. Sells 494,259 Shares of Ventas, Inc. $VTR

Posted by Geri Gentry on Jul 22nd, 2026

CI Investments Inc. lowered its position in Ventas, Inc. (NYSE:VTR – Free Report) by 21.4% during the 1st quarter, Holdings Channel reports. The fund owned 1,812,752 shares of the real estate investment trust’s stock after selling 494,259 shares during the period. Ventas makes up 0.7% of CI Investments Inc.’s portfolio, making the stock its 29th largest holding. CI Investments Inc.’s holdings in Ventas were worth $148,247,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in VTR. Wiser Advisor Group LLC acquired a new position in Ventas during the third quarter worth $27,000. IFC & Insurance Marketing Inc. acquired a new position in shares of Ventas during the fourth quarter valued at about $30,000. Elyxium Wealth LLC bought a new stake in shares of Ventas during the fourth quarter worth about $33,000. Reflection Asset Management bought a new stake in shares of Ventas during the fourth quarter worth about $34,000. Finally, Manchester Capital Management LLC raised its holdings in shares of Ventas by 60.5% in the 4th quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock worth $38,000 after acquiring an additional 185 shares during the last quarter. Institutional investors and hedge funds own 94.18% of the company’s stock.

Insider Buying and Selling

In other news, Director Michael J. Embler bought 2,500 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was acquired at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This represents a 14.97% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Walter C. Rakowich sold 1,152 shares of the stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the sale, the director directly owned 28,349 shares in the company, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.53% of the stock is owned by corporate insiders.

Ventas Price Performance

Shares of NYSE VTR opened at $97.55 on Wednesday. Ventas, Inc. has a twelve month low of $65.15 and a twelve month high of $97.64. The stock’s 50 day moving average price is $87.62 and its 200-day moving average price is $84.45. The company has a market capitalization of $47.43 billion, a PE ratio of 177.37, a PEG ratio of 2.07 and a beta of 0.70. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings results on Monday, April 27th. The real estate investment trust reported $0.11 EPS for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue was up 22.0% compared to the same quarter last year. During the same period in the previous year, the business posted $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts anticipate that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Investors of record on Tuesday, June 30th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date of this dividend was Tuesday, June 30th. Ventas’s payout ratio is 378.18%.

Wall Street Analyst Weigh In

A number of analysts have commented on VTR shares. The Goldman Sachs Group reissued a “buy” rating and set a $110.00 price objective on shares of Ventas in a report on Tuesday, May 19th. JPMorgan Chase & Co. raised their target price on Ventas from $93.00 to $94.00 and gave the company an “overweight” rating in a report on Monday, May 11th. UBS Group lifted their target price on Ventas from $85.00 to $93.00 and gave the company a “neutral” rating in a research report on Monday, May 4th. Evercore reiterated an “outperform” rating and set a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. Finally, Jefferies Financial Group increased their price target on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Fourteen research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $96.17.

Check Out Our Latest Research Report on VTR

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.